Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome.

In patients with acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), a recent ARDS Network randomized controlled trial demonstrated that a low tidal volume (VT) mechanical ventilation strategy (6 ml/kg) reduced mortality by 22% compared with traditional mechanical ventilation (12 ml/kg). In this study, we examined the relative efficacy of low VT mechanical ventilation among 902 patients with different clinical risk factors for ALI/ARDS who participated in ARDS Network randomized controlled trials. The clinical risk factor for ALI/ARDS was associated with substantial variation in mortality. The risk of death (before discharge home with unassisted breathing) was highest in patients with sepsis (43%); intermediate in subjects with pneumonia (36%), aspiration (37%), and other risk factors (35%); and lowest in those with trauma (11%) (p < 0.0001). Despite these differences in mortality, there was no evidence that the efficacy of the low VT strategy varied by clinical risk factor (p = 0.76, for interaction between ventilator group and risk factor). There was also no evidence of differential efficacy of low VT ventilation in the other study outcomes: proportion of patients achieving unassisted breathing (p = 0.59), ventilator-free days (p = 0.58), or development of nonpulmonary organ failure (p = 0.44). Controlling for demographic and clinical covariates did not appreciably affect these results. After reclassifying the clinical risk factors as pulmonary versus nonpulmonary predisposing conditions and infection-related versus non-infection-related conditions, there was still no evidence that the efficacy of low VT ventilation differed among clinical risk factor subgroups. In conclusion, we found no evidence that the efficacy of the low VT ventilation strategy differed among clinical risk factor subgroups for ALI/ARDS.

[1]  D. Morabito,et al.  Initial severity of metabolic acidosis predicts the development of acute lung injury in severely traumatized patients , 2000, Critical care medicine.

[2]  E. Ruokonen,et al.  Acute respiratory distress syndrome: frequency, clinical course, and costs of care. , 1999, Critical care medicine.

[3]  F. Jardin,et al.  Improved prognosis of acute respiratory distress syndrome 15 years on , 1999, Intensive Care Medicine.

[4]  R. Kacmarek,et al.  Current definitions of acute lung injury and the acute respiratory distress syndrome do not reflect their true severity and outcome , 1999, Intensive Care Medicine.

[5]  Kristian Antonsen,et al.  Incidence and Mortality after Acute Respiratory Failure and Acute Respiratory Distress Syndrome in Sweden, Denmark, and Iceland , 1999 .

[6]  C. Brun-Buisson,et al.  Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients. , 1999, JAMA.

[7]  S. Belknap,et al.  A Randomized Controlled Trial of Filgrastim as an Adjunct to Antibiotics for Treatment of Hospitalized Patients with Community-Acquired Pneumonia , 1998 .

[8]  J. Dhainaut,et al.  Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. , 1998, American journal of respiratory and critical care medicine.

[9]  P. Pelosi,et al.  Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes? , 1998, American journal of respiratory and critical care medicine.

[10]  M. Bullinger,et al.  Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome. , 1998, Critical care medicine.

[11]  T. Evans,et al.  Comparison of nose and face mask CPAP therapy for sleep apnoea , 1998, Thorax.

[12]  C. Carvalho,et al.  Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. , 1998, The New England journal of medicine.

[13]  D. Raasch,et al.  Wall energy and wall thickness of exchange-coupled rare-earth transition-metal triple layer stacks , 1997 .

[14]  G. Bernard,et al.  A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group. , 1997, Chest.

[15]  H. Folkesson,et al.  Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. , 1995, The Journal of clinical investigation.

[16]  K. Steinberg,et al.  Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. , 1995, JAMA.

[17]  R B Schoene,et al.  Recovery of function in survivors of the acute respiratory distress syndrome. , 1994, American journal of respiratory and critical care medicine.

[18]  T. Evans,et al.  Adult respiratory distress syndrome: has there been a change in outcome predictive measures? , 1994, Thorax.

[19]  J. Pittet,et al.  Alveolar epithelial injury and pleural empyema in acute P. aeruginosa pneumonia in anesthetized rabbits. , 1993, Journal of applied physiology.

[20]  J. Pittet,et al.  Pseudomonas aeruginosa-induced lung and pleural injury in sheep. Differential protective effect of circulating versus alveolar immunoglobulin G antibody. , 1993, The Journal of clinical investigation.

[21]  S. Peters,et al.  A multicenter registry of patients with acute respiratory distress syndrome. Physiology and outcome. , 1992, The American review of respiratory disease.

[22]  T. Clemmer,et al.  The adult respiratory distress syndrome. A report of survival and modifying factors. , 1992, Chest.

[23]  W. Knaus,et al.  The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. , 1991, Chest.

[24]  R. Simon,et al.  Bayesian subset analysis. , 1991, Biometrics.

[25]  J. Peters,et al.  Clinical Determinants of Abnormalities in Pulmonary Functions in Survivors of the Adult Respiratory Distress Syndrome , 1989, The American review of respiratory disease.